Last updated on February 2019

DE-117 Spectrum 5 Study

Brief description of study

Santen will evaluate the intraocular pressure (IOP) lowering effect and efficacy of DE-117 ophthalmic solution 0.002% in latanoprost/non-responder subjects diagnosed with POAG or OHT

Clinical Study Identifier: NCT03697811

Contact Investigators or Research Sites near you

Start Over

Santen Inc Clinical Operations

Arizona Eye Center
Chandler, AZ United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.